Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Implant or insert
Patent
1998-04-30
1999-12-07
Weber, Jon P.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Implant or insert
602 50, A61F 200
Patent
active
059978953
ABSTRACT:
Dural substitutes are provided, which include collagen treated and/or prepared to be physiologically compatible and substantially free of active viruses and prions. Suitable forms for the dural substitutes include a sponge, a film, a non-woven matrix, a felt or a combination of at least two of the foregoing forms. Also provided are a method for preparing dural substitutes and a method for promoting meningeal tissue growth.
REFERENCES:
patent: 3157524 (1964-11-01), Artandi
patent: 3520402 (1970-07-01), Nichols et al.
patent: 4016877 (1977-04-01), Cruz, Jr. et al.
patent: 4066083 (1978-01-01), Ries
patent: 4578067 (1986-03-01), Cruz, Jr.
patent: 5019087 (1991-05-01), Nichols
patent: 5667839 (1997-09-01), Berg
Adegbite, A. B.; Paine, K. W.; Rozdilsky, B. The role of neomembranes in formation of hematoma around Silastic dura substitue. Case report. J. Neurosurg. 1983 Feb; 58(2): 295-7.
Anonymous. Creutzfeldt-Jakob disease in patients who received a cadaveric dura mater graft--Spain, 1985-1992. MMWR Morb Mortal Wkly Rep. Jul. 23, 1993; 42(28):560-3.
Anonymous. Leads from the MMWR. Update: Creutzfeldt-Jakob disease in a patient receiving a cadaveric dura mater graft. JAMA. Jul. 17, 1987; 258(3): 309-10.
Anonymous. Leads from the MMWR. Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. JAMA. Feb. 24, 1989; 261(8): 1118.
Anonymous. Update: Creutzfeldt-Jakob disease in a patient receiving a cadaveric dura mater graft. MMWR. Morb Mortal Wkly Rep. Jun. 5, 1987; 36(21):324-5.
Anonymous. Update: Creutzfeldt-Jakob disease in a second patient who received a cadaveric dura mater graft. MMWR Morb. Mortal Wkly Rep. Jan. 27, 1989; 38(3):37-8, 43.
Antoine, J. C.; Michel D.; Bertholon, P.; Mosnier, J. F.; Laplanche, J. L.; Beaudry, P.; Hauw, J. J.; Veyret, C. Creutzfeldt-Jakob disease after extracranial dura mater embolization for a nasopharyngeal angiofibroma. Neurology. 1997 May; 48(5):1451-3.
Awwad, E. E.; Smith, K. R. Jr; Martin, D. S.; Manealli, A. Unususal hemorrhage with use of synthetic dural substitute: MR findins. J. Comput Assist Tomogr. 1991 Jul.; 15(4):618-20.
Banerjee, T.; Meagher, J. N.; Hunt, W. E. Unusual complications with use of silastic dural substitute. Am. Surg. 1974 Jul; 40(7):434-7.
Berrington, N. R. Acuten extradural hematoma associated with silastic dural substitute: case report. Surg Neurol. 1992 Dec; 38(6):469-70.
Brown, P.; Cervenakova, L.; Goldfarb, L. G.; McCombie, W. R.; Rubenstein, R.; Will, R. G.; Pocchiari, M.; Martinez-Lage, J. F.; Scalici, C.; Masullo, C.; et al. Iatrogenic Creutzfeldt-Jakob disease: an example of the interplay between ancient genes and modern medicine. Neurology. 1994 Feb; 44(2):291-3.
Clavel, M.; Clavel, P. Creutzfeldt-Jakob disease transmitted by dura mater graft. Eur Neurol. 1996; 36(4):239-40.
Cohen, A. R.; Aleksic, S.; Ransohoff, J. Inflammatory reaction to synthetic dural substitute. Case report. J. Neurosurg. 1989 Apr; 70(4):633-5.
Defebvre, L.; Destee, A.; Caron, J.; Ruchoux, M. M.; Wurtz, A.; Remy, J. Creutzfeldt-Jakob disease after an embolization of intercostal arteries with cadaveric dura mater suggesting a systemic transmission of the piron agent. Neurology. 1997 May; 48(5):1470-1.
Esmode, T.; Lucek, C. J.; Symon, L.; Duchen, L. W.; Will, R. G. Creutzfeldt-Jakob disease and lyophilised dura mater grafts: report of two cases. J. Neurol Neurosurg Psychiatry. 1993 Sep; 56(9):999-1000.
Fisher, W. S. 3d; Six, E.G. Cervical myelopathy from dural substitute. Neurosurgery. 1983 Dec; 13(6):715-7.
Fontana, R.; Talamonti, G.; D'Angelo, V.; Arena, O.; Monte, V.; Colice, M. Spontaneous haematoma as unusual complication of silastic dural substitute. Report of 2 cases. Acta Neurochir. 115(1-2(Wien) 1992):64-6.
Gondo, G. et al. A Posterior fossa hemorrhage 11 years after the use of silastic dural substitute: case report. [Japanese with English abstract]. No Shinkei Geka. 1991. Jan; 19(1):59-62.
Gudmundsson, G.; Sogaard, I. Complications to the use of vicryl-collagen dural substitute. Acta Neurochir. 132(1-3 (Wien) 1995): 145-7.
Hainfellner, J. A.; Jellinger, K.; Dringer, H.; Guentchev, M.; Kleinert, R.; Pilz, P.; Maier, H.; Budka, H. Creutzfeldt-Jakob disease in Austria. [German with English abstract]. Wien Klin Wochenschr. Dec. 13, 1996; 108(23): 759-63.
Harvey, I.; Coyle, E. Creutzfeldt-Jakob disease after non-cmmercial dura mater graft. Lancet. Sep. 5, 1992; 340(8819):615.
Janetta et al., "Formaldehyde-treated, regenerated collagen film and film-laminate as a substitute for dura mater." 16 Surg. Forum 435 (1965).
Johnson, M. H.; Thompson, E. J. Freeze-dried cadaveric dural grafts can stimulate a damaging immune response in the host. Eur. Neurol. 1981; 20(6):445-7.
Lane, K. L.; Brown, P.; Howeel, D. N.; Crain, B. J.; Hulette, C. M.; Burger, P. C.; DeArmond, S. J. Creutzfeldt-Jakob disease in a preganat woman with an implanted dura mater graft. Neurosurgery. 1994 Apr;34(4):737-9; discussion 739-40.
Laquerriere, Annie M.D., et al. "Experimental evaluation of bilayered human collagen as a dural substitute" J Neurosurg 1993 78:487-491.
Martinez-lage, J. F.; Sola, J.; Poza, M.; Esteban, J. A. Pediatric Creutzfeldt-Jakob disease: probable transmission by a dural graft. Childs Nerv Syst. 1993 Jul; 9(4):239-42.
Marx, R. E.; Carlson, E. R. Creutzfeldt-Jakob disease from allogenic dura: a review of risks and safety. J. Oral Maxillofac Surg. 1991 Mar.; 49(3):272-274; discussion 274-275.
Misra, B. K.; Shaw, J. F. Extracrebral hematoma in association with dural substitute. Neurosurgery. 1987 Sep; 21(3):399-400.
Miyamoto, S. et al. "Formation of postoperative hematoma directly under a silastic dural substitute." [Japanese with English Abstract.] No Shinkei Geka. 1983 Sep; 11(9)989-994.
Newcombe, R. L. Neurosurgery and iatrogenic transmission of Creutzfeldt-Jakob disease. Med J Aust. May 20, 1996; 164(10):603-4.
Ng, T. H.; Chan, K. H.; Leung, S. Y.; Mann, K. S. An unusual complication of silastic dural substitute: case report. Neurosurgery. 1990 Sep;27(3):491-3.
Ohbayashi, N.; Inagawa, T.; Katoh, Y.; Kumano, K.; Nagasakio, R.; Hada, H. Complication of silastic dural substitute 20 years after dural plasty. Surg Neurol. 1994 Apr;41(4):338-41.
Ongkiko, C. M. Jr; Keller, J. T.; Mayfield, F. H.; Dunsker, S. B. An unusual complication of Dura Film as a dural substitute. Report of two cases. J. Neurosurg. 1984 May;60(5):1076-9.
Pocchiari, M.; Masullo, C.; Salvatore, M.; Genuardi, M.; Galgani, S. Creutzfeldt-Jakob disease after non-commerical dura mater graft. Lancet. Sep. 5, 1992; 340(8819):614-5.
Robertson, S. C.; Menezes, A. H. Hemorrhagic complications in association with silastic dural substitute: pediatric and adult case reports with a review of the literature. Neurosurgery. 1997 Jan;40(1):201-5; discussion 205-6.
Santos, Garcia, J. M.; Lopez Corbalan, J. A.; Martinez-Lage, J. F.; Sicilia Guillen, J. CT and MRI in iatrogenic and sporadic Creutzfeldt-Jakob disease: as far as imaging perceives. Neuroradiology. 1996 Apr; 38(3):226-31.
Siccardi, D.; Ventimigilia, A. Fibrotic-haemorrhagic reaction to synthetic dural substitute. Acta Neurochir. 132(1-3(Wien) 1995): 148-9.
Simpson, D.; Robson, A. Recurrent Subarachnoid bleeding in association with dural substitute. Report of three cases. J Neurosurg. 1984 Feb;60(2):408-9.
Thadani, V.; Penar, P. L.; Partington, J.; Kalb, R.; Janssen, R.; Schonberger, L. B.; Rabkin, C. S.; Prichard, J. W. Creutzfeldt-Jakob disease probably acquired a cadaveric dura mater graft. Case report. J Neurosurg. 1988 Nov;69(5):766-9.
Taylor, D. M.; McConnell, I. Unconventional transmissible agents in dura mater: significance for iatrogenic Creutzfeldt-Jakob disease. Neuropathol Appl Neurobiol. 1996 Jun;22(3): 259-60.
Thompson, D.; Taylor, W.; Hayward, R. Haemorrhage associated with silastic dural substitute. J Neurol Neuorsurg Psychiatry. 1994 May;57(5):646-8.
Weber, T.; Tumani, H.; Holdorff, B.; Collinge, J.; Palmer M.; Kretzschmar, H. A.; Felgenhauer, K. Transmission of Creutzfeldt-Jakob disease by handling of dura mater. Lnacet. Jan. 9, 1993;341(8837):123-4.
Yamada, S.; Aiba, T.; Endo, Y.; Hara, M.; Kita
Archibald Simon J.
McKinney, III George W.
Narotam Pradeep K.
O'Fee Robert P.
O'Grady Judith
Integra Lifesciences Corporation
Weber Jon P.
LandOfFree
Dural/meningeal repair product using collagen matrix does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dural/meningeal repair product using collagen matrix, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dural/meningeal repair product using collagen matrix will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-820811